Creative Biolabs Updated Antibody Products to Power Up Virology Research

January 11 22:09 2022
Possessing expertise in antibody development and production, Creative Biolabs has established a center of viral antibody products, gathering multitype antibodies against extensive virus species to support global customers’ projects involving viruses and viral variants, such as SARS-CoV-2.

New York, USA – January 11, 2022 – Firstly detected in November 2021, Omicron rapidly spreads globally. According to the British Medical Journal (BMJ), this variant’s genome contains approximately 50 mutations, including changes in the spike protein. It did not directly evolve from the Delta variant, according to scientists, but it did feature the typical modifications observed in Alpha, Beta, Gamma, and Delta variants.

Many scientists have been working hard throughout this time to figure out what the appearance of this variant implies for the epidemic. With ample in-stock virus antibody products (e.g., anti-SARS-CoV antibodies), Creative Biolabs can ensure quick delivery to give a hand to customers’ projects.

Product Type

* Primary antibodies are unconjugated immunoglobulins that bind to antigens directly, generated from hosts like mouse, rabbit, goat, or chicken in the form of both monoclonal and polyclonal.

* A secondary antibody is usually conjugated, which needs to bind to a primary antibody to detect, sort, and purify the antigen of interest. The prerequisites of secondary antibody applicability are the specificity for the antibody species and the isotype of the primary antibody used.

* Isotype controls have similar properties with primary antibodies when utilized, which do not bind antigens and are used as the negative control group to distinguish non-specific background signals from specific ones.

* Pseudoviruses: powerful virological research tools that are safe and versatile, which can be applied in pseudovirus-based inhibition assays for detecting neutralizing antibodies and anti-virus entry inhibitors and evaluation of the neutralizing antibodies induced by a vaccine candidate.

* Pseudohost: an artificially developed stable cell line expressing the specific receptor, such as human angiotensin-converting enzyme 2 (hACE2) that can be utilized in the study of SARS-CoV-2, for the detection of neutralizing antibodies and anti-virus entry inhibitors, the evaluation of neutralizing antibodies induced by a vaccine, and the exploration of virus entry mechanism.

“We have a wide variety of virus antibodies,” said a scientist, “covering almost all the virus species that are studied for pharmaceutical and research purposes.”

Visit the official website of Creative Biolabs to learn more:


Creative Biolabs is a dedicated supplier of viral antibody products, which has been providing comprehensive antibody types for the research with different objectives. As a reward of years of exploration and accumulation, the viral antibodies available cover all the mainstream research targets in the industry, such as adenovirus, ebola virus, hepatitis virus. In the fight against COVID-19, Creative Biolabs also made some contributions with its in-stock antibodies against different proteins of SARS-CoV-2.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States